BRIEF-Foundation Medicine receives FDA approval of Foundationfocus

* Foundation Medicine receives FDA approval of

Foundationfocus CDXBRCA as a companion diagnostic for

Rubraca(Rucaparib) for the treatment of women with ovarian

cancer

Source text for Eikon:

Further...

Read more